Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josh DeClercq

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Current Medical Research and Opinion|July 8, 2020
Statistical considerations for medication adherence researchJosh DeClercq, Leena Choi
JAMA|August 15, 2023
Renin-Angiotensin System Modulation in Adults With COVID-19-ReplyWesley H Self, Josh DeClercq, Michael Orr, et al.
Journal of the American Pharmacists Association : Japha|March 9, 2026
Implementing an electronic flowsheet for biologics requiring infusions and injections in inflammatory bowel diseaseJessica Fann, Miranda Murray, Josh DeClercq, et al.
The American Journal of Managed Care|December 14, 2020
Rheumatoid arthritis medication adherence in a health system specialty pharmacyNate Berger, Megan Peter, Josh DeClercq, et al.
Journal of Managed Care & Specialty Pharmacy|March 31, 2024
Cost avoidance from health system specialty pharmacist interventions in patients with multiple sclerosisDarina Georgieva, Brandon Markley, Josh DeClercq, et al.
Archives of Orthopaedic and Trauma Surgery|October 30, 2023
Does interaction occur between risk factors for revision total knee arthroplasty?Georges J Bounajem, Josh DeClercq, Garen Collett, et al.
AIDS and Behavior|June 2, 2023
Optimizing HIV PrEP Persistence: Does Your Pharmacy Matter?Kristen Whelchel, Autumn D Zuckerman, Josh DeClercq, et al.
Journal of Clinical Lipidology|April 3, 2022
Exploring rates of PCSK9 inhibitor persistence and reasons for treatment non-persistence in an integrated specialty pharmacy modelDustin R Donald, Victoria W Reynolds, Nicole Hall, et al.
Journal of Managed Care & Specialty Pharmacy|February 27, 2026
Comparing rates of primary medication nonadherence and turnaround time among patients at a health system specialty pharmacy compared with external specialty pharmaciesKatie R Cruchelow, Sarah Layne, Josh DeClercq, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 7, 2026
The impact of early oral anticancer medication monitoring through electronic patient assessmentsBrooke Looney, Tiffany Bui, Josh DeClercq, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Current Medical Research and Opinion|July 8, 2020
Statistical considerations for medication adherence researchJosh DeClercq, Leena Choi
JAMA|August 15, 2023
Renin-Angiotensin System Modulation in Adults With COVID-19-ReplyWesley H Self, Josh DeClercq, Michael Orr, et al.
Journal of the American Pharmacists Association : Japha|March 9, 2026
Implementing an electronic flowsheet for biologics requiring infusions and injections in inflammatory bowel diseaseJessica Fann, Miranda Murray, Josh DeClercq, et al.
The American Journal of Managed Care|December 14, 2020
Rheumatoid arthritis medication adherence in a health system specialty pharmacyNate Berger, Megan Peter, Josh DeClercq, et al.
Journal of Managed Care & Specialty Pharmacy|March 31, 2024
Cost avoidance from health system specialty pharmacist interventions in patients with multiple sclerosisDarina Georgieva, Brandon Markley, Josh DeClercq, et al.
Archives of Orthopaedic and Trauma Surgery|October 30, 2023
Does interaction occur between risk factors for revision total knee arthroplasty?Georges J Bounajem, Josh DeClercq, Garen Collett, et al.
AIDS and Behavior|June 2, 2023
Optimizing HIV PrEP Persistence: Does Your Pharmacy Matter?Kristen Whelchel, Autumn D Zuckerman, Josh DeClercq, et al.
Journal of Clinical Lipidology|April 3, 2022
Exploring rates of PCSK9 inhibitor persistence and reasons for treatment non-persistence in an integrated specialty pharmacy modelDustin R Donald, Victoria W Reynolds, Nicole Hall, et al.
Journal of Managed Care & Specialty Pharmacy|February 27, 2026
Comparing rates of primary medication nonadherence and turnaround time among patients at a health system specialty pharmacy compared with external specialty pharmaciesKatie R Cruchelow, Sarah Layne, Josh DeClercq, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 7, 2026
The impact of early oral anticancer medication monitoring through electronic patient assessmentsBrooke Looney, Tiffany Bui, Josh DeClercq, et al.
Pageof 6